| 000 | 01725 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250516054625.0 | ||
| 264 | 0 | _c20120425 | |
| 008 | 201204s 0 0 eng d | ||
| 022 | _a1540-8183 | ||
| 024 | 7 |
_a10.1111/j.1540-8183.2011.00664.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aIto, Hiroki | |
| 245 | 0 | 0 |
_aPerformance of everolimus-eluting versus paclitaxel-eluting coronary stents in small vessels: results from the SPIRIT III and SPIRIT IV clinical trials. _h[electronic resource] |
| 260 |
_bJournal of interventional cardiology _cDec 2011 |
||
| 300 |
_a505-13 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAngioplasty, Balloon, Coronary |
| 650 | 0 | 4 |
_aAntineoplastic Agents, Phytogenic _xadministration & dosage |
| 650 | 0 | 4 | _aCoronary Angiography |
| 650 | 0 | 4 |
_aCoronary Restenosis _xprevention & control |
| 650 | 0 | 4 | _aDrug-Eluting Stents |
| 650 | 0 | 4 | _aEverolimus |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xadministration & dosage |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPaclitaxel _xadministration & dosage |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aSirolimus _xadministration & dosage |
| 650 | 0 | 4 | _aStatistics as Topic |
| 700 | 1 | _aHermiller, James B | |
| 700 | 1 | _aYaqub, Manejeh | |
| 700 | 1 | _aNewman, William | |
| 700 | 1 | _aSood, Poornima | |
| 700 | 1 | _aWang, John C | |
| 700 | 1 | _aCannon, Louis | |
| 700 | 1 | _aMaddux, James E | |
| 700 | 1 | _aSudhir, Krishnankutty | |
| 700 | 1 | _aStone, Gregg W | |
| 773 | 0 |
_tJournal of interventional cardiology _gvol. 24 _gno. 6 _gp. 505-13 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1540-8183.2011.00664.x _zAvailable from publisher's website |
| 999 |
_c21159250 _d21159250 |
||